GSA Capital Partners’s Bionano Genomics BNGO Stock Holding History

GSA Capital Partners’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Sell	150,284 -203,079	-57%	-$245K	0.01%	1564
2026 Q1	$413K	Buy	353,363 +15,586	+5%	+$20K	0.03%	1037
2025 Q4	$517K	Buy	+337,777	New	+$585K	0.04%	783
2025 Q3	–	Sell	-40,076	Closed	-$131K	–	1668
2025 Q2	$131K	Buy	+40,076	New	+$150K	0.01%	1590
2024 Q4	–	Sell	-1,674	Closed	-$46K	–	1620
2024 Q3	$46K	Buy	+1,674	New	+$52.1K	﹤0.01%	1521
2024 Q2	–	Sell	-9,163	Closed	-$610K	–	1638
2024 Q1	$610K	Buy	9,163 +7,715	+533%	+$576K	0.05%	764
2023 Q4	$164K	Buy	+1,448	New	+$151K	0.01%	1360
2022 Q1	–	Sell	-92	Closed	-$164K	–	1422
2021 Q4	$164K	Buy	+92	New	+$246K	0.02%	1254

Other funds holding BNGO

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CWP

Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

GSA Capital Partners's BNGO Position: Q2 2026 in Review

GSA Capital Partners reduced its Bionano Genomics (BNGO) stake by 57% in Q2 2026, selling an estimated $245K and leaving 150,284 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #1564.

GSA Capital Partners first reported a position in BNGO in Q4 2021 and has held it in 8 quarters since. The position peaked at $610K in Q1 2024. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

GSA Capital Partners held 150,284 shares of Bionano Genomics worth $170K as of Q2 2026.
GSA Capital Partners sold 203,079 Bionano Genomics shares in Q2 2026, an estimated $245K.
Bionano Genomics made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1564 holding.
GSA Capital Partners first reported a position in Bionano Genomics in Q4 2021 and has held it in 8 quarters since.
GSA Capital Partners's Bionano Genomics position peaked at $610K in Q1 2024.
9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.